Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

DOPORIO 25MG/100 MG COMPRIMIDOS EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/DOPORIO 25MG/100 MG COMPRIMIDOS EFG

Approved

STANDARD

DOPORIO 25MG/100 MG COMPRIMIDOS EFG

Orion Corporation🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jun 1, 2023
Approval ID: 2804117c2f0fa861
Company: Orion Corporation
Type: Standard

Approval Details

Approval Id: 2804117c2f0fa861
Drug Cima Aemps Name: DOPORIO 25MG/100 MG COMPRIMIDOS EFG
Register Number: 88637
Holder Company Name: Orion Corporation
Marketing Company Name: Orion Pharma S.L.
Holder Company Detail Path: /organization/orion-corporation
Authorization Date: 2023-06-01
Dosage Form: COMPRIMIDO
Dose: 25/100 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Orion Corporation
Company Detail Path: /organization/orion-corporation

Company Information

Pharmaceutical Company Name: Orion Corporation
Name En: Orion Corporation (Orion Oyj)
Country Name: Finland
City Name: Espoo
Address: Espoo, Finland
Website: https://www.orionpharma.com

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jun 1, 2023

Approval ID

2804117c2f0fa861

Type

Standard

Back to CIMA-AEMPS Approvals